Dolutegravir Renal Impairment Study

Clinical trial NCT01353716 · COMPLETED

Trial details

NCT number: NCT01353716
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2011-06-01
Primary completion: 2012-04-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.